Related Experiment Video
Updated: Jun 16, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Biotransformations at Syngenta: A Focused Perspective on Metabolites and Natural Products
Andrew Gomma1, David J Burns2, Nicholas P Mulholland3
1Syngenta Crop Protection AG, Schaffhauserstrasse 101, CH-4332 Stein. andrew.gomm@syngenta.com.
Abstract:
In this article we present our perspective on how biotransformations can contribute to key sustainability challenges faced by the agrochemical industry. We focus on two key areas where biotransformations have enabled research breakthroughs, the preparative synthesis of metabolite standards and natural products. Increasingly stringent regulatory requirements have rendered early metabolite identification and production an expanding activity to progress an active ingredient to the market. We present a collaborative project on unspecific peroxygenases for selective oxidation of pyrethroid-related compounds, illustrating future directions in research for the production of metabolites. Natural products provide an opportunity to explore a vast chemical space and to have an improved sustainability profile. Nevertheless, their fermentation at large scale and low cost is still challenging, and we present strategies aiming at increasing the fermentation titre and batch purity.
Related Concept Videos
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

